☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Reject
The US FDA Rejects Sesen Bio's Vicineum (oportuzumab monatox-qqrs) for the Treatment of BCG-Unresponsive NMIBC
August 16, 2021
The US FDA's Rejects FibroGen's Roxadustat for the Treatment of Anemia Due to CKD
August 11, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.
